Alzheimer's disease (AD) is prevalent throughout the world and is the leading cause of
dementia in older individuals (aged≥ 65 years). To gain a deeper understanding of the …

There is an extensive literature relating to factors associated with the development of
Alzheimer's disease (AD), but less is known about factors which may contribute to its …

Introduction Variability exists in the disease trajectories of Alzheimer's disease (AD) patients.
We performed a genome‐wide association study to examine rate of cognitive decline (ROD) …

Background: The course of Alzheimer's disease (AD) varies considerably between
individuals. There is limited evidence on factors important for disease progression …

Abstract Background/Aims: Alzheimer disease (AD) is particularly devastating, with no cure,
no means of prevention, and no proven way to slow progression. AD is associated with the …

Background Rapidly progressive forms of Alzheimer's disease (rpAD) are increasingly
recognized and may have a prevalence of up to 30% of patients among all patients with …

Introduction The objective of this study was to define current assistive technology and
telecare (ATT) practice for people with dementia living at home. Methods This is a …

Background: There is evidence that adipokines have roles in brain functioning and cognitive
decline. Objective: Assess the role of leptin and adiponectin levels in predicting changes in …

Background There are no published longitudinal studies from Africa of people with dementia
seen in memory clinics. The aim of this study was to determine the proportions of the …

Background: Impact of Alzheimer's disease (AD) progression on patient health-related
quality of life (HRQoL), caregiver time, and societal costs is not well characterized in early …